Literature DB >> 24696366

Ocular inflammatory disease in patients with polymyalgia rheumatica: A case series and review of the literature.

Sepideh Faez1, Ann-Marie Lobo1, Sebastian H Unizony2, John H Stone2, George N Papaliodis1, Lucia Sobrin3,4.   

Abstract

Scleritis and uveitis are potentially blinding conditions that can be associated with systemic inflammatory diseases. Polymyalgia rheumatica (PMR) is a common rheumatic disorder of the elderly of uncertain etiology. Although there are a few published reports of scleritis and uveitis in PMR patients, the association of PMR to ocular inflammation has not been well established. The aim of this study is to report a series of PMR patients with scleritis and/or uveitis and review the prior published reports of this potential association. We retrospectively reviewed the medical charts of patients with PMR and scleritis or uveitis who were examined in the Ocular Immunology Service of Massachusetts Eye and Ear Infirmary. We also performed a systematic literature search (PubMed; January 1990 until January 2014) to identify earlier published reports. Seven PMR patients with ocular inflammatory disease (OID) were included in our study: two with scleritis, three with anterior uveitis, and two with panuveitis. The onset of PMR preceded the occurrence of OID in six patients, and in one patient uveitis developed 2 months prior to PMR. Five patients demonstrated a temporal association between flares of PMR and OID. In four patients, OID flares developed during tapering of systemic prednisone prescribed for PMR. Four of the five patients who had relapsing PMR had recurrent or persistent uveitis over the course of follow-up. PMR may be associated with both scleritis and uveitis and should be considered as a possible underlying cause of OID.

Entities:  

Keywords:  Episcleritis; Ocular inflammatory disease; Polymyalgia rheumatica; Scleritis; Uveitis

Mesh:

Substances:

Year:  2014        PMID: 24696366     DOI: 10.1007/s10067-014-2558-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  48 in total

Review 1.  Polymyalgia rheumatica in 2011.

Authors:  Alessandra Soriano; Raffaele Landolfi; Raffaele Manna
Journal:  Best Pract Res Clin Rheumatol       Date:  2012-02       Impact factor: 4.098

2.  Posterior scleritis and polymyalgia rheumatica.

Authors:  I G Simmons; E E Kritzinger; P I Murray
Journal:  Eye (Lond)       Date:  1997       Impact factor: 3.775

3.  Efficacy of tocilizumab in two patients with anti-TNF-alpha refractory uveitis.

Authors:  Aurore Muselier; Philip Bielefeld; Samuel Bidot; Julien Vinit; Jean-François Besancenot; Alain Bron
Journal:  Ocul Immunol Inflamm       Date:  2011-10       Impact factor: 3.070

4.  Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.

Authors:  Hiroshi Haruta; Nobuyuki Ohguro; Minoru Fujimoto; Satoshi Hohki; Fumitaka Terabe; Satoshi Serada; Shintaro Nomura; Kohji Nishida; Tadamitsu Kishimoto; Tetsuji Naka
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-17       Impact factor: 4.799

5.  Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.

Authors:  S Unizony; L Arias-Urdaneta; E Miloslavsky; S Arvikar; A Khosroshahi; B Keroack; J R Stone; J H Stone
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-11       Impact factor: 4.794

6.  Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study.

Authors:  F Moosig; N Czech; C Mehl; E Henze; R A Zeuner; M Kneba; J O Schröder
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

7.  Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis.

Authors:  N E Roche; J W Fulbright; A D Wagner; G G Hunder; J J Goronzy; C M Weyand
Journal:  Arthritis Rheum       Date:  1993-09

8.  Giant cell arteritis presenting with uveitis.

Authors:  Stephanie N Slemp; Sarah E Martin; Richard A Burgett; Eyas M Hattab
Journal:  Ocul Immunol Inflamm       Date:  2013-10-21       Impact factor: 3.070

9.  Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA.

Authors:  Michele F Doran; Cynthia S Crowson; W Michael O'Fallon; Gene G Hunder; Sherine E Gabriel
Journal:  J Rheumatol       Date:  2002-08       Impact factor: 4.666

10.  [Biphosphonates and intraocular inflammation].

Authors:  V M Asensio Sánchez; G Botella Oltra; E Carrasco
Journal:  Arch Soc Esp Oftalmol       Date:  2004-02
View more
  2 in total

Review 1.  Ocular manifestations of rheumatic diseases.

Authors:  Adam Kemeny-Beke; Peter Szodoray
Journal:  Int Ophthalmol       Date:  2019-10-03       Impact factor: 2.031

2.  Ocular Manifestations in Colombian Patients with Systemic Rheumatologic Diseases.

Authors:  Pilar Uribe-Reina; Juliana Muñoz-Ortiz; Carlos Cifuentes-González; Juliana Reyes-Guanes; Juan Pablo Terreros-Dorado; William Zambrano-Romero; Carolina López-Rojas; Fabien Mantilla-Sylvain; Rubén Darío Mantilla-Hernández; Alejandra de-la-Torre
Journal:  Clin Ophthalmol       Date:  2021-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.